Grigorios Siokas Acquires 79,254 Shares of Cosmos Health Inc. (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 79,254 shares of the company’s stock in a transaction dated Monday, May 19th. The shares were bought at an average price of $0.43 per share, for a total transaction of $34,079.22. Following the acquisition, the chief executive officer now owns 5,661,320 shares in the company, valued at approximately $2,434,367.60. This trade represents a 1.42% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, April 23rd, Grigorios Siokas bought 205,000 shares of Cosmos Health stock. The stock was bought at an average price of $0.40 per share, with a total value of $82,000.00.
• On Monday, April 21st, Grigorios Siokas bought 654,912 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.32 per share, for a total transaction of $209,571.84.
• On Monday, March 3rd, Grigorios Siokas purchased 132,572 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.49 per share, with a total value of $64,960.28.
• On Monday, February 24th, Grigorios Siokas acquired 354,296 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.56 per share, for a total transaction of $198,405.76.

Cosmos Health Stock Performance

Shares of NASDAQ COSM traded up $0.04 during trading hours on Tuesday, reaching $0.46. The stock had a trading volume of 236,956 shares, compared to its average volume of 872,083. The company has a market cap of $12.66 million, a price-to-earnings ratio of -0.19 and a beta of 5.50. Cosmos Health Inc. has a twelve month low of $0.28 and a twelve month high of $1.58. The business’s fifty day moving average is $0.42 and its two-hundred day moving average is $0.59. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%. As a group, research analysts expect that Cosmos Health Inc. will post -0.78 EPS for the current year.

Institutional Trading of Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC raised its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 as of its most recent filing with the Securities and Exchange Commission. 12.61% of the stock is owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.